Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis

NCT01119287 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: Dexamethasone 0.1% ophthalmic suspension
DRUG: Olopatadine hydrochloride 0.1% ophthalmic solution
OTHER: Inactive ingredients, used as placebo

Sponsor

Alcon Research